Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hims & Hers Health Inc. Class A HIMS

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.


Recent & Breaking News (NYSE:HIMS)

Hims & Hers Health, Inc. to Host Virtual Annual Meeting of Shareholders

Business Wire May 17, 2021

Hims & Hers Health, Inc. Reports First Quarter 2021 Financial Results

Business Wire May 17, 2021

Hims & Hers Health, Inc. Announces Response to Recent SEC Guidance Applicable to Warrants Issued by Special Purpose Acquisition Companies ("SPACs")

Business Wire May 4, 2021

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Business Wire March 18, 2021

Hims & Hers Appoints Two New Board Members

Business Wire March 10, 2021

Hims & Hers Health, Inc. to Participate in Upcoming Investor Conference

Business Wire February 17, 2021

Hims & Hers Health, Inc. to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call

Business Wire February 10, 2021